Medline (MDLN) Equity Ratio (2024 - 2026)

Medline (MDLN) has 3 years of Equity Ratio data on file, last reported at 0.29 in Q1 2026.

• Quarterly Equity Ratio changed N/A year-over-year to 0.29 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.29 (changed N/A YoY) and the FY2025 annual result came in at 0.28, down 37.88% from the prior year.
• Equity Ratio improved to 0.29 in Q1 2026 per MDLN's latest filing, from 0.28 in the prior quarter.
• Across five years, Equity Ratio topped out at 0.45 in Q4 2024 and bottomed at 0.28 in Q4 2025.
• The 3-year median for Equity Ratio is 0.29 (2026), against an average of 0.34.
• Peak annual rise in Equity Ratio reached 37.88% in 2025, while the deepest fall reached 37.88% in 2025.
• Tracing MDLN's Equity Ratio over 3 years: stood at 0.45 in 2024, then sank by 37.88% to 0.28 in 2025, then gained by 3.56% to 0.29 in 2026.
• Per Business Quant, the three latest MDLN Equity Ratio figures stand at 0.29 (Q1 2026), 0.28 (Q4 2025), and 0.45 (Q4 2024).

Peer Comparison